Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Lawton

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Advances in Radiation Oncology|October 21, 2020
Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual MeetingGita Suneja, Malcolm D Mattes, Raymond B Mailhot Vega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02Gerald E Hanks, Thomas F Pajak, Arthur Porter, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.
Practical Radiation Oncology|October 17, 2018
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
The Journal of Urology|February 15, 2019
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2018
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerJeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2020
VA-Radiation Oncology Quality Surveillance ProgramMichael Hagan, Rishabh Kapoor, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlasHiram A Gay, H Joseph Barthold, Elizabeth O'Meara, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Advances in Radiation Oncology|October 21, 2020
Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual MeetingGita Suneja, Malcolm D Mattes, Raymond B Mailhot Vega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02Gerald E Hanks, Thomas F Pajak, Arthur Porter, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.
Practical Radiation Oncology|October 17, 2018
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
The Journal of Urology|February 15, 2019
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2018
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C Morgan, Karen Hoffman, D Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerJeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2020
VA-Radiation Oncology Quality Surveillance ProgramMichael Hagan, Rishabh Kapoor, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlasHiram A Gay, H Joseph Barthold, Elizabeth O'Meara, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
Pageof 5